Los Angeles Cancer Center Acquires another 102 Leaf DMLC from LinaTech
05-14-2011

LOS ANGELES, UNITED STATES, June. 23, 2011 -- A leading cancer clinic has acquired a second 102 Leaf DMLC for use on another one of their linear accelerators to begin delivering advanced radiotherapy treatments. Many patients have been treated using the existing 102 Leaf DMLC for fast, precise radiotherapy since its initial use at Valley Cancer Institute in Culver City/Los Angeles.

James Gonzalez – lead medical physicist, said, "we have successfully treated hundreds of patients with essentially zero downtime."

Valley Cancer Institute serves many hundreds of patients each year and this number is expected to increase due to the acquisition of a second 102 Leaf DMLC. The Institute uses equipment and software from a variety of suppliers but is moving more towards using LinaTech as their main supplier for specific RT machines and software.

About LinaTech
LinaTech, headquartered in Sunnyvale, California, is a leading manufacturer of medical devices and software for treating cancer with radiotherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Additional information is available through www.linatech.com.

LinaTech Contact:
Simon Bhangal
Director of Sales and Marketing

LinaTech
Email: simon_bhangal@linatech.com
Phone: +1 408 733 2051